CRISPR Therapeutics
$7.63 B
๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Share price
Change (1 day)
Change (1 year)

Market capitalization of CRISPR Therapeutics (CRSP)

Market cap: $7.63 Billion

As of October 2021 CRISPR Therapeutics has a market cap of $7.63 Billion. This makes CRISPR Therapeutics the world's 1911th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of CRISPR Therapeutics from 2016 to 2021

Year Market cap Change
2021$9.43 B-13.47%
2020$10.90 B194.5%
2019$3.70 B149.9%
2018$1.48 B56.74%
2017$0.94 B17.19%
2016$0.80 B